Feb.10 -- Teva Pharmaceutical Industries Ltd. Chief Executive Officer Kare Schultz discusses the company's plans to produce and distribute Covid-19 vaccines and says Teva is ready to settle thousands of opioid lawsuits. He speaks with Bloomberg's Guy Johnson and Alix Steel on "Bloomberg Markets: European Close."